A Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma
Brief description of study
A Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Melanoma
-
Age: Between 18 Years - 120 Years
-
Gender: All
Male or Female, Age 18-120, Has histologically or cytologically confirmed melanoma
Updated on
09 Mar 2024.
Study ID: 843504
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
